# Effects of Rosuvastatin on Aortic Stenosis Progression

> **NCT00800800** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 378 (estimated)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00800800
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 378 (ESTIMATED)
- **Last updated:** 2010-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800800, "Effects of Rosuvastatin on Aortic Stenosis Progression". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00800800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*